Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

How can pharma engage with the top performing STPs?

The recent announcement by Health Secretary Jeremy Hunt on which Sustainability and Transformation Partnerships (STPs) would benefit from a share of the £325m capital funding allocated in the Spring Budget,...

Wilmington Healthcare

Roche Basel Switzerland

Roche gets FDA OKs for Alecensa and Zelboraf

Gains US licences for first-line use in lung cancer and a rare blood cancer

- PMLiVE

Dr Jan van de Winkel joins Austrian biotech Hookipa

Joins the firm's board of directors, taking up the chairman's role

- PMLiVE

Apeiron bolsters management board

Peter Llewellyn-Davies joins as its CFO and CBO

The great schism

Technological advances in our industry are about to exacerbate societal inequality

Celgene building

Celgene gains French reimbursement for Revlimid in multiple myeloma

HAS decides it offers ' significant improvement' over existing treatments

- PMLiVE

Novartis files CAR-T therapy CTL109 in Europe

Analysts predict Kymriah could become a $1bn-plus product in Europe

- PMLiVE

Vertex’s tezacaftor/ivacaftor shows lung function boost

The combination therapy is currently under review in Europe and the US

Sobi appoints Torbjorn Hallberg as general counsel

He joins the rare diseases healthcare group from Takeda

Ashfield bolsters leadership team with two new hires

Beverley Gall and Tony Woods join as performance directors

- PMLiVE

GSK’s R&D head Vallance departs, possibly for government role

An independent panel of scientists proposed the UK role to Vallance, according to the FT

(Left to right) Brian Parsons, Jon Hallows, Gordon Muir-Jones, Kevin Ryder

Porterhouse Medical announces expansion into the US

  6 November 2017; Reading, UK – UK-based Porterhouse Medical Ltd is delighted to announce the opening of a subsidiary in Philadelphia, PA, USA. The new entity, Porterhouse Medical US, is...

Porterhouse Medical Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links